Smartphone apps could be the key to kicking the habit for good, with new research finding they are nearly three times as effective as trying to quit with no or minimal support.
A pooled analysis of global data, published in the journal BMJ Evidence Based Medicine, indicates that digital tools — particularly those using psychological techniques — could become a “cornerstone” of tobacco control efforts worldwide.
While quitting smoking often relies on willpower or limited access to counselling, the study found that apps offer an “accessible and versatile” alternative that puts intensive support in a smoker’s pocket.
The psychology of success
The researchers analysed 31 studies involving over 12,000 participants to determine what actually works. They found a clear divide in the type of software available.
Most apps fall into two categories: traditional tools that track smoking behaviour, or “psychological” apps that use techniques like Cognitive Behavioural Therapy (CBT), mindfulness, and acceptance therapy to change how a smoker thinks and regulates emotion.
The analysis showed that apps grounded in these psychological theories were significantly more effective, increasing abstinence rates by 36 per cent over six months compared with standard tracking apps.
The overall impact of adding a smartphone to a quit plan was substantial:
- Apps vs. No Support: Apps used alone were nearly three times as effective as no or minimal support for keeping people off cigarettes for six months.
- Apps + Counselling: When combined with traditional face-to-face support, apps nearly doubled the success rate.
- Apps + Medication: When added to pharmacotherapy (such as nicotine patches or gum), apps improved success rates by 77 per cent.
The researchers argue that apps solve the logistical problems of traditional healthcare.
“Smartphone apps can deliver intensive, interactive and real-time behavioural support, exceeding the effect of brief advice,” the researchers noted.
“A clear dose–response relationship exists between counselling intensity and quit success, and apps help meet this need while bypassing barriers such as limited clinic capacity, staff time, and declining use of telephone quitlines.”
However, the team cautioned that the current certainty of evidence remains “low” due to small sample sizes and variations in app design. They emphasised that while the findings are promising, high-quality clinical trials are needed to confirm the results.
“Should future evidence confirm lasting benefits… rigorously validated apps could become a cornerstone of global tobacco control efforts,” they concluded.
